Long-term prophylaxis of spontaneous baterial peritonitis in patients with cirrhosis

Annals of Pharmacotherapy

Volumn 39, Issue 5, 2005, Pages 908-912

  Frazee, Lawrence A ^a,b   Marinos, Antonio E ^a   Rybarczyk, Amy M ^a   Fulton, Scott A ^b,c  

^a AKRON GENERAL MEDICAL CENTER   (United States)

^b NE OH Universities Coll of Medicine ^*  (United States)

^c Gastroenterology Group Inc   (United States)

Author keywords

Antimicrobial; Ascites; Cirrhosis; Peritonitis

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; NORFLOXACIN;

ANTIMICROBIAL THERAPY; ASCITES FLUID LEVEL; BACTERIAL PERITONITIS; CLINICAL TRIAL; HUMAN; LIVER CIRRHOSIS; LONG TERM CARE; META ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; SECONDARY PREVENTION;

ANTI-BACTERIAL AGENTS; ASCITES; BACTERIAL INFECTIONS; CLINICAL TRIALS; HUMANS; LIVER CIRRHOSIS; PERITONITIS; PROGNOSIS;

EID: 17644367519     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E585     Document Type: Review

References (27)

1. Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med 2004;350:1646-54.
2. Gines P, Martin PY, Neiderberger M. Prognostic significance of renal dysfunction in cirrhosis. Kidney Int Suppl 1997;61:S77-82.
3. Mowat C, Stanley AJ. Review article: spontaneous bacterial peritonitis-diagnosis, treatment and prevention. Aliment Pharmacol Ther 2001;15:1851-9.
4. Bernard B, Grange J-D, Khac EN, Amiot X, Oplon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999;29:1655-61.
5. Andreu M, Sola R, Sitges-Serra A, Alia C, Gallen M, Vila MC, et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 1993;104:1133-8.
6. Tito L, Rimola A, Gines P, Llach J, Arroyo V, Rodes J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988;8:27-31.
7. Bhuva M, Ganger D, Jensen D. Spontaneous bacterial peritonitis: an update on evaluation, management, and prevention. Am J Med 1994;97:169-75.
8. Parsi MA, Atreja A, Zein NN. Spontaneous bacterial peritonitis: recent data on incidence and treatment. Cleve Clin J Med 2004;71:569-76.
9. Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988;95:1351-5.
10. Toledo C, Salmeron J-M, Rimola A, Navasa M, Arroyo V, Llach J, et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993;17:251-7.
11. Suzuki K, Takikawa Y. Marked improvement in the resolution of, and survival rates in, spontaneous bacterial peritonitis. J Gastroenterol 2002;37:149-50.
12. Soriano G, Guarner C, Tomas A, Villanueva C, Torras X, Gonzalez D, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992;103:1267-72.
13. Rimola A, Bory F, Teres J, Peres-Ayuso RM, Arroyo V, Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985;5:463-7.
14. Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Levy V-G. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology 1996;24:802-6.
15. Blaise M, Pateron D, Trinchet J-C, Levacher S, Beaugrand M, Pourriat J-L. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1994;20:34-8.
16. Hsieh WJ, Lin HC, Hwang SJ, Hou MC, Lee FY, Chang FY, et al. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol 1998;93:962-6.
17. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000;32:142-53.
18. Llach J, Rimola A, Navasa M, Gines P, Salmeron JM, Gines A, et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992;16:724-7.
19. Guarner C, Sola R, Soriano G, Andreu M, Novella MT, Vila MC, et al. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 1999;117:414-9.
20. Runyon BA, Morrissey RL, Hoefs JC, Wyle FA. Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. Hepatology 1985;5:634-7.
21. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988;8:632-5.
22. Rolachon A, Cordier L, Bacq Y, Nousbaum J-B, Franza A, Paris J-C, et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 1995;22:1171-4.
23. Singh N, Gayowski T, Yu VL, Wagener MM. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med 1995;122:595-8.
24. Soriano G, Guarner C, Teixido M, Such J, Barrios J, Enriquez J, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 1991;100:477-81.
25. Novella M, Sola R, Soriano G, Andreu M, Gana J, Ortiz J, et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 1997;25:532-6.
26. Grange J-D, Roulot D, Pelletier G, Pariente E-A, Denis J, Ink O, et al. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol 1998;29:430-6.
27. Gines P, Rimola A, Planas R, Vargas V, Marco F, Almela M, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990;12:716-24.